1,019
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Liposomes/Chitosan Scaffold/Human Fibrin Gel Composite Systems for Delivering Hydrophilic Drugs—Release Behaviors of Tirofiban In Vitro

, &
Pages 149-157 | Received 10 Aug 2007, Accepted 10 Oct 2007, Published online: 10 Oct 2008

REFERENCES

  • Allen M., Hansen C., Martin F., Redemann C., Young A. Y. Liposome containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivo. Biochem. Biophs. Acta 1991; 1066: 29–36
  • Bergquist P. A., Manas D., Hunke W. A., Reed R. A. Stability and compatibility of Tirofiban hydrochloride during simulated Y-site administration with other drugs. Am. J. Health. Syst. Pharm. 2001; 58: 1218–1223
  • Blanco D., Alonso M. J. Protein encapsulation and release from poly (lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur. J. Pharm. Biopharm. 1998; 45: 285–294
  • Castile J. D., Taylor K. M. G. Factors affecting the size distribution of liposomes produced by freeze-thaw extrusion. Int. J. Pharm 1999; 188: 87–95
  • Chapman C. J., Erdahl W. L., Taylor R. W., Pfeiffer D. R. Factor affecting solute entrapment in phospholipid vesicles prepared by the freeze-thaw extrusion method: a possible general method for improving the efficiency of entrapment. Chem. Phys. Lipids 1990; 55: 73–83
  • Chung T. W., Huang Y. Y., Tsai Y. L., Liu Y. Z. Effects of solvent evaporation rate on the properties of protein-loaded PLLA and PDLLA microspheres fabricated by emulsion-solvent evaporation process. J. Microencap. 2002a; 19: 463–471
  • Chung T. W., Tyan Y. C., Hsieh J. H., Wang S. S., Chu S. H. Shear stress-induced aggregation of oxidized platelets. Thromb Res. 2002b; 105: 325–329
  • Chung T. W., Lu Y. F., Wang S. S., Lin Y. S., Chu S. H. Growth of human endothelial cells on the photochemically grafted Gly-Arg-Gly-Asp (GRGD) chitosans. Biomaterials. 2003; 23: 4803–4809
  • Chung T. W., Yang M. G., Tsai W. J. A fibrin encapsulated liposomes- in-chitosan matrix (FLCM) for delivering water-soluble drugs, Influences of the surface properties of liposomes and crosslinked fibrin network. Int. J. Pharm. 2006; 311: 122–129
  • Cohen S., Yoshioka T., Lucarrelli M., Hwang L. H., Langer R. Controlled delivery systems for proteins based on poly (lactic/glycolic acid) microspheres. Pharm. Res. 1991; 8: 713–720
  • Ho H. O., Hsiao C. C., Chen C. Y., Sokoloski T. D., Sheu M. T. Fibrin-based drug delivery systems, II. The preparation and characterization of micro-beads. Drug. Dev. Ind. Pharm. 1994; 20: 535–546
  • Ichinose A., Tamaki T., Aoki N. Factor XIII-mediated cross-linking of NH2-terminal peptide of α2-plasmin inhibitor to fibrin. FEBS Lett 1983; 152: 369–371
  • Madihally S. V., Matthew H. W. T. Porous chitosan scaffolds for tissue engineering. Biomaterials 1999; 20: 1133–1142
  • Maes M., Planken M. V., Gastel A. V., Desnyder R. Blood coagulation and platelet aggregation in major depression. J. Affect. Disord 1996; 40: 35–40
  • Manning M. C., Patel K., Borchardt R. T. Stability of protein pharmaceuticals. Pharm. Res. 1989; 6: 903–918
  • Meyenburg S., Lilie H., Panzner S., Rudolph R. Fibrin encapsulated liposomes as protein delivery system studies on the in vitro release behavior. J. Contr. Rel. 2000; 69: 159–168
  • Moribe K., Maruyama K., Iwatsuru M. Molecular localization and state of amphotericin B in PEG liposomes. Int. J. Pharm. 1999; 193: 97–106
  • Park S. H., Park S. R., Chung S. I., Pai K. S., Min B. H. Tissue-engineering cartilage using fibrin / hyaluronan composite gel and its in vivo implantation. Artif. Organs. 2005; 29: 838–845
  • Prism-Plus Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor: inhibition with Tirofiban in unstable angina and non-Q-wave myocardial infarction. N. Engl. J. Med. 1998; 38: 1488–1497
  • Restore Investigators. Effects of platelet glycoprotein IIb/ IIIa blockade with Tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 1997; 96: 1445–1453
  • Sakiyama-Elbert S., Hubbell J. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J. Contr. Rel. 2000; 65: 389–402
  • Sandor M., Riechel A. I., Kaplan A., Mathiowitz E. Effect of Lecithin and MgCO3 as additives on the enzymatic activity of carbonic anhydrase encapsulated in poly (lactide-co-glycolide) (PLGA) microspheres. Biochim. Biophys. Acta. 2002; 1570: 63–74
  • Schense J. C., Hubbell J. A. Cross-linking exogenous bifunctional peptides into fibrin gels Factor XIIIa. Bioconj. Chem. 1999; 10: 75–81
  • Shu X. Z., Zhu K. J., Song W. Novel pH-sensitive citrate cross-linked chitosan film for drug release. Int. J. Pharm. 2001; 212: 19–28
  • Tabata Y., Gutta S., Langer S. Controlled delivery systems for proteins using polyanhydride microspheres. Pharm. Res. 1993; 10: 487–496
  • Takeuchi H., Kojima H., Yamamoto H., Kawashima Y. Evaluation of circulation profiles of liposomes coated with water-soluble polymers having different molecular weights in rats. J. Contr. Rel. 2001; 75: 83–91
  • Yang M. G. Porous Chitosan Membrane for Controlled Drug Release from a Liposome/Fibrin System. Master Thesis, Dept. of Biomedical Engineering, Chung-Yuan Christian University, Chung Li. Taiwan, ROC 2003
  • Ye Q., Zund G., Benedikt P., Jockennoevel S., Hoerstrup S. P., Sakyama S., Hubbell J. A., Turina M. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur. J. Cardiothor. Surg. 2000; 17: 587–591

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.